NCT07367009

Brief Summary

The aim of this thesis is to evaluate the effects of adding an anterior femoral cutaneous nerve (AFCN) block to the adductor canal block used for postoperative analgesia after total knee arthroplasty on the postoperative inflammatory response, as assessed by inflammatory biomarkers including NLR, PLR, AISI, and CAR.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
9mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Jan 2026Jan 2027

First Submitted

Initial submission to the registry

January 17, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

January 19, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2027

Expected
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2027

Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

January 17, 2026

Last Update Submit

January 26, 2026

Conditions

Keywords

total knee arthroplastyadductor canal blockanterior femoral cutaneous nerve blockpostoperative analgesiainflammatory biomarkers

Outcome Measures

Primary Outcomes (1)

  • assessment of post operative inflammatuar markes

    The primary objective of this observational study is to evaluate the effect of adding an anterior femoral cutaneous nerve block to the adductor canal block on the inflammatory response, as assessed by biomarkers such as NLR, PLR, AISI, and CAR, in patients undergoing total knee arthroplasty.

    it will be recorded at 0, 15, and 30 minutes in the PACU, and at 2, 4, 8, 12, and 24 hours on the ward.

Secondary Outcomes (1)

  • postoperative opioid consumption, wound healing

    it will be recorded at 0, 15, and 30 minutes in the PACU, and at 2, 4, 8, 12, and 24 hours on the ward.

Study Arms (2)

patients who peripheral nerve block applied

patients who adductor canal block and anterior femoral cutaneous nerve block applied

patients without peripheral nerve block

patients who do not receive adductor canal block and anterior femoral cutaneous nerve block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 18 years and older, scheduled for elective unilateral total knee arthroplasty under spinal anesthesia (SA), classified as American Society of Anesthesiologists (ASA) physical status I-III, and who provided written informed consent after being informed one day before surgery on the ward, will be included.

You may qualify if:

  • Patients scheduled for elective unilateral total knee arthroplasty under spinal anesthesia
  • Aged 18 years and older
  • Body mass index (BMI) \<40 kg/m²
  • ASA physical status I-III
  • Provision of written informed consent

You may not qualify if:

  • Revision or bilateral surgery
  • General anesthesia or conversion to general anesthesia due to failed block
  • BMI ≥40 kg/m²
  • ASA physical status \>III
  • Local infection, hematoma, previous surgery, or deformity at the block site
  • Coagulopathy or history of hematologic, renal, or hepatic disease; advanced respiratory or cardiac failure; malignancy
  • Use of anticoagulant therapy
  • History of local anesthetic allergy or toxicity
  • Impaired cooperation, Alzheimer's disease, dementia, psychiatric or neurological disorders, or language/communication barriers
  • Chronic analgesic use, chronic alcohol consumption, or substance abuse
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatih Sultan Mehmet Training and Research Hospital

Istanbul, ataşehir, 34752, Turkey (Türkiye)

Location

Related Publications (3)

  • Razzaz M.; Youssif G.; Wahba S.; Mohamed S.; Mohamed A. Analgesic efficacy of ultrasound guided anterior femoral cutaneous nerve block (AFCNB) plus femoral triangle block (FTB) vs. adductor canal block (ACB) in total knee arthroplasty, Anaesthesia, Pain & Intensive Care, 2025

    BACKGROUND
  • Domagalska M, Ciftsi B, Janusz P, Reysner T, Kolasinski J, Wieczorowska-Tobis K, Kowalski G. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) levels following erector spinae plane block (ESPB) in posterior lumbar decompression: a randomized, controlled trial. Eur Spine J. 2023 Dec;32(12):4192-4199. doi: 10.1007/s00586-023-07913-z. Epub 2023 Sep 5.

  • Domagalska M, Reysner T, Kowalski G, Daroszewski P, Mularski A, Wieczorowska-Tobis K. Pain Management, Functional Recovery, and Stress Response Expressed by NLR and PLR after the iPACK Block Combined with Adductor Canal Block for Total Knee Arthroplasty-A Prospective, Randomised, Double-Blinded Clinical Trial. J Clin Med. 2023 Nov 14;12(22):7088. doi: 10.3390/jcm12227088.

Study Officials

  • oznur demiroluk, as prof

    fatih sultan mehmet traing and research hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

January 17, 2026

First Posted

January 26, 2026

Study Start

January 19, 2026

Primary Completion (Estimated)

January 20, 2027

Study Completion (Estimated)

January 30, 2027

Last Updated

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations